This is a routine initial ownership disclosure for a new insider. Monitor future Form 4 filings for any open-market purchases or grants that could signal insider conviction.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $65.05entry
- T+1 · 7d ago −3.31%α −2.94% · $62.90
- T+5 · 16h ago −15.46%α −13.77% · $54.99
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Ansuman Satpathy filed a Form 3 initial statement of beneficial ownership with the SEC, reporting no securities owned as of October 28, 2026. The filing is a routine administrative requirement for a new insider and contains no financial data or trading activity.
Key Facts
- Form 3 filed by Ansuman Satpathy as a reporting owner of 10x Genomics, Inc.
- Period of report is October 28, 2026.
- No securities ownership reported on the Form 3.
- Power of Attorney executed on October 26, 2026, appointing Randy Wu and James Bryant as attorneys-in-fact for Section 16 filings.
Financial Impact
No financial impact; no securities owned or transacted.
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001610717-26-000449 |
| Document: 0001610717-26-000449-index-headers.html | 0001610717-26-000449 |
| Document: 0001610717-26-000449-index.html | 0001610717-26-000449 |
| Document: 0001610717-26-000449.txt | 0001610717-26-000449 |
Track record
28 reports on TXG
1 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 7 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
- Nov 6, 202610d ago 3 Neutral 1/10 Viewing Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
- Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
- Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
- Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers